Blood Coagulation Disorders, Inherited - 23 Studies Found
| Completed |
: Evaluation of Hemostasis in Bleeding and Thrombotic Disorders :
: 2005-09-12 |
| Completed |
: Education Program for Patients Receiving Oral Anticoagulation :
|
| Completed |
: A Gene Transfer Study for Hemophilia A : Hemophilia A : 2016-12-16 : Genetic: SPK-8011 A novel, bio-engineered, recombinant adeno-associated viral vector carrying human fact |
| Withdrawn |
: Study of Recombinant Factor IX Product, IB1001, in Previously Treated Subjects With Hemophilia B : Hemophilia B : 2013-11-14 : Biological: IB1001 Prophylaxis (during Treatment and Conti |
| Completed |
: BAY14-2222 Prophylaxis and Joint Function Improvement (Adults) :
: 2007-12-21 : Drug: Kogenate (BAY14-2222) One group two treatment schedules, first on-demand then switch to prophylaxi |
| Completed |
: Epidemiology and Immunology of Hemophilia A Inhibitors :
: 2000-05-25 |
| Not yet recruiting |
: Bleeding Risk Evaluation in Haemophilia Patients Under Antiplatelet Therapies : Hemophilia : 2017-05-16 : Other: Non interventionnal study A query form to all concerned patients by each investigating centre wil |
| Available |
: An Expanded Access Program of Emicizumab in Participants With Hemophilia A With Inhibitors : Hemophilia A : 2017-05-12 : Biological: Emicizumab Participants will receive emicizumab at a loading dose of 3 milligrams per kilogr |
| Not yet recruiting |
: DDAVP vs. Exercise : Children With Mild Hemophilia A : 2017-04-27 :
|
| Not yet recruiting |
: Study of rFVIIIFc for ITI in Haemophilia A Patients With Inhibitors Who Have Failed Previous ITI Therapies : Hemophilia A : 2017-03-31 : Biological: Recombinant coagulation factor (rFVIIIFc) rFVI |